To be specific, treating mice with TNBS increased the colonic expression of IL-6, TNF-α, IL-1β, and IFN-γ, colitis score, and intestinal permeability; this was fully reversed by pelargonidin administration [72]. The gene discussed is IL6; the disease is colitis.